Literature DB >> 2412343

Functional analysis of reverse transcription by a frameshift pol mutant of murine leukemia virus.

L I Messer, K M Currey, B J O'Neill, J V Maizel, J G Levin, B I Gerwin.   

Abstract

Endogenous reverse transcription by wild-type murine leukemia virus (MuLV) was compared to that catalyzed by clone 23, a pol mutant containing a reverse transcriptase protein which lacks the carboxyl-terminal third of the molecule (J. G. Levin, S. C. Hu, A. Rein, L. I. Messer, and B. I. Gerwin (1984), J. Virol. 51, 470-478). Competition immunoassays revealed that mutant virions contain normal amounts of polymerase protein, indicating that the lack of carboxyl-terminal sequences does not alter normal processing of enzyme precursors. Although the mutant enzyme was previously shown to have the ability to copy and degrade RNA:DNA hybrids, the present study demonstrates that it is defective in functions required to generate full-length copies of viral DNA. Analysis of products of endogenous reverse transcription showed that minus-strand strong-stop DNA is formed and that mutant virions synthesize a series of minus-strand DNA intermediates up to 2.2 kb in length. Comparison of mutant and wild-type MuLV reaction products indicated that the 2.2-kb termination site of the mutant corresponds to a normal pausing region for the wild-type enzyme. Computer analysis of sequences and structure within pausing regions suggested the involvement of C-rich consensus sequences plus multibranch loop structures in the general phenomenon of enzyme-pausing during reverse transcription.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412343     DOI: 10.1016/0042-6822(85)90062-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli.

Authors:  S C Hu; D L Court; M Zweig; J G Levin
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.

Authors:  J Guo; L E Henderson; J Bess; B Kane; J G Levin
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

Authors:  J G Levin; R J Crouch; K Post; S C Hu; D McKelvin; M Zweig; D L Court; B I Gerwin
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 5.  Identifying and characterizing Hfq-RNA interactions.

Authors:  M A Faner; A L Feig
Journal:  Methods       Date:  2013-05-23       Impact factor: 3.608

6.  Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.

Authors:  J Guo; T Wu; J Bess; L E Henderson; J G Levin
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.

Authors:  W Wu; L E Henderson; T D Copeland; R J Gorelick; W J Bosche; A Rein; J G Levin
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.